Citigroup
BCAB icon

Citigroup’s BioAtla BCAB Stock Holding History

Citigroup’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-523
Closed -$18K – 6080
2025
Q3 		$18K Buy
+523
New +$12.1K ﹤0.01% 4856
2025
Q1 		– Sell
-129
Closed -$3.8K – 5589
2024
Q4 		$3.8K Buy
129
+8
+7% +$671 ﹤0.01% 5496
2024
Q3 		$10.6K Sell
121
-4
-3% -$335 ﹤0.01% 5279
2024
Q2 		$8.55K Sell
125
-42
-25% -$5K ﹤0.01% 5180
2024
Q1 		$28.8K Buy
167
+36
+27% +$4.47K ﹤0.01% 4911
2023
Q4 		$16.1K Buy
131
+119
+992% +$10.3K ﹤0.01% 5056
2023
Q3 		$1.05K Sell
12
-268
-96% -$34.2K ﹤0.01% 5088
2023
Q2 		$41.9K Buy
280
+269
+2,445% +$46.3K ﹤0.01% 4730
2023
Q1 		$1.41K Sell
11
-807
-99% -$145K ﹤0.01% 5129
2022
Q4 		$337K Buy
818
+770
+1,604% +$319K ﹤0.01% 3426
2022
Q3 		$18K Buy
48
+19
+66% +$6.22K ﹤0.01% 4775
2022
Q2 		$4K Sell
29
-55
-65% -$8.75K ﹤0.01% 5661
2022
Q1 		$21K Sell
84
-1,328
-94% -$555K ﹤0.01% 5110
2021
Q4 		$1.39M Buy
1,412
+874
+162% +$1.12M ﹤0.01% 2935
2021
Q3 		$792K Sell
538
-261
-33% -$508K ﹤0.01% 3265
2021
Q2 		$1.69M Buy
799
+777
+3,532% +$1.76M ﹤0.01% 2792
2021
Q1 		$56K Buy
22
+18
+450% +$46.1K ﹤0.01% 4641
2020
Q4 		$6K Buy
+4
New +$6.69K ﹤0.01% 7069

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup's BCAB Position: Q4 2025 in Review

Citigroup sold out of BioAtla (BCAB) in Q4 2025, closing a stake of 523 shares — an estimated $18K sold.

Citigroup first reported a position in BCAB in Q4 2020 and held it in 18 quarters. The position peaked at $1.69M in Q2 2021. 41 funds tracked by Wall St. Rank hold BCAB as of Q4 2025.

  • Citigroup reported no remaining BioAtla position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 523 BioAtla shares in Q4 2025, an estimated $18K.
  • Citigroup first reported a position in BioAtla in Q4 2020 and held it in 18 quarters.
  • Citigroup's BioAtla position peaked at $1.69M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.